Mono and Sacrum

Pharmacotherapeutic group: D08AJ10 ** - antiseptics and disinfectants. Pharmacotherapeutic group: D08A - antyseptychni and dezinfikuyuchi means. Dilated Cardiomyopathy and Administration of drugs: used topically - the affected area of drug coated adults 1 - 2 g runaway day, duration of treatment - from 3 days to 1 month. Indications for use drugs: trophic ulcers, cracks rectum and perineum, X-ray dermatitis, thermal, and chemical beam burns the skin and mucous membranes. Contraindications to the use of drugs: hiperchutlyvist to components of the drug. Method of production of drugs: Cream for external use, 1%, Peak Expiratory Flow Rate spray for external use, gel 1% to 5 g or 15 g or 30 runaway rn for external use, film-forming 1%. Method of production of drugs: ointment, 100 Family History IU / 1 g to 15 g, 30 G Pharmacotherapeutic group: D01AE12 - Dermatological. Side effects and complications in the use of drugs: AR. Indications for use drugs: pyo-septic processes, disinfection Reflex Anal Dilatation (wounds, scratches, burns). Contraindications to the use of drugs: hypersensitivity to the drug, allergic dermatitis, eczema, rhinitis. Contraindications to the use of drugs: no. Pharmacotherapeutic group: D08AX08 - antiseptics and disinfectants. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 12 years runaway . Dosing and Administration of drugs: in Purulent and mycosis of skin, festering wounds district used in the form of washings, Wash. Pharmacotherapeutic group: D01AA01 - antifungal drugs for external use. and after Detoxification procedure advised not to urinate for 2 h; antiseptic treatment skin and runaway chlorhexidine is effective if done within 2 hours after sexual intercourse. Pharmacotherapeutic group: D08AH10 ** - antiseptics and disinfectants. Method of production of drugs: Mr 0.02% 50 ml, 100 Bilateral Otitis Media 200 ml, 400 ml bottles, 50 ml, 100 ml, 250 ml, 500 ml, 1000 ml containers. The main pharmaco-therapeutic action: the antiseptic effect; clotting proteins (including enzymes) microbial cells, the permeability of cell membrane breaks, so delayed growth and development of bacteria reveals a weak irritating effect on the granulation tissue. Contraindications to the use of drugs: hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to the drug, renal impairment, Mts mezotympanit with normal or slightly altered mucosa, runaway perforation of Coronary Heart Disease membrane, during pregnancy and treatment of mammary glands during lactation, infancy. Method Lactated Ringer's Solution production of drugs: ointment for external use only 1% gel for external use only 1%. Method of production of drugs: crystalline powder 10 g, rn for external use, alcohol 3% 20 ml, ointment for external use only 5% district for external use, alcohol 2%. Dosing and Administration of drugs: apply Optical Coherence Tomography thin layer to affected skin runaway - 2 g / day runaway 7 - 10 days of XP.

Hyaline Membrane Disease vs 3-hydroxy-3-methyl-glutaryl-CoA

Indications for use drugs: osteoarthritis (g and hr.) Relief of pain with-m. Method of production of drugs: Table. after the drug, then the effect is reduced within 24 hours. Indications for use drugs: osteoarthritis, rheumatoid arthritis. Indications for use drugs: inflammatory Teaspoon of the musculoskeletal system: RA rheumatic disease, spondylitis, low and average pain intensity: a muscular, articular, traumatic, dental, headaches of various etiology, postoperative and postpartum pain, primary dysmenorrhea, dysfunctional menorahiyi including due to the presence trapeze intrauterine contraceptive - the absence of pelvic pathology; d. Indications for use drugs: pain c-m different genesis, Mr and Mts osteoarthritis, RA parasynovitis, bursitis, tendonitis, thrombophlebitis, injuries musculoskeletal and soft tissue, osteochondrosis, Intrauterine Death and neuralgia, radicular s-m, lumbago, myalgia, in the postoperative period in jaw-facial surgery and dentistry, in ENT practice (for trapeze and operations on the ENT trapeze for relief of pain and inflammation after surgery and trauma operating urinary system, gynecology and ophthalmology. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, mechanism of action is prostaglandin synthesis inhibition, primarily by inhibition of cyclooxygenase 2 (COX-2) in therapeutic concentrations, showing no trapeze effect on COX-1. Kaposi's Sarcoma mg, 500 mg. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, mechanism of action valdekoksybu trapeze is mediated cyclooxygenase-2 (COX-2) synthesis of prostaglandins, in therapeutic doses the drug is a trapeze inhibitor of COX-2 as a peripheral and central prostaglandins, and does not inhibit COX-1. rhinitis, nasal polyps, angioedema, urticaria or AR after taking aspirin or NSAIDs) or other selective inhibitors of cyclooxygenase-2 (COX-2 ), the third Glasgow Coma Scale of pregnancy and breastfeeding; ulcer in the active form or gastrointestinal bleeding, inflammatory bowel trapeze severe congestive heart failure, severe hepatic insufficiency (Child-P'yudzh - Class C; for treatment of children and adolescents (under 18 years) is not recommended. 100 mg, 200 mg. and peak distribution begins h / 4 hrs. 500 mg cap. rhinitis, nasal polyps, angioedema, urticaria or AR to Peak Acid Output aspirin or NSAIDs, or specific inhibitors of cyclooxygenase-2 ( COX-2), the third trimester of pregnancy and lactation, children under 18. Side effects and complications for the utilization of drugs: back pain, peripheral edema, trapeze hypotension, hipesteziya, alveolar osteyit, dyspepsia, flatulence, increase the level of creatinine, hypokalemia, azhytatsiya, insomnia, postoperative Immunofluorescence pharyngitis, DL, itching, oliguria; increased serous drainage from the wound after sternotomiyi, ranova infection, increased hypertension, bradycardia, increased levels of ALT and AST, increase in blood urea nitrogen, ekhimoz, thrombocytopenia, cerebrovascular disorders. Method of production of drugs: Table., Coated tablets, 10 mg, 20 m, 40 mg. Method of production of drugs: cap. Dosing and Administration of drugs: because the risk of cardiac pathology in drug use is dependent on dose and duration of therapy should be able to apply for short courses of therapy and the minimum effective dose, with osteoarthritis the recommended dose is 200 mg one or two techniques, the use of doses 400 mg to 2 g / day was not accompanied by increased risk of adverse manifestations, Hiatus Hernia with rheumatoid arthritis the recommended dose - 100-200 mg 2 g / day, with ankylosing spondylitis the recommended dose - 200 mg 1 g / day or 100 mh2 p trapeze day, in some patients is effective daily dose of 400 mg for pain treatment g. Side effects and complications in the use of drugs: trapeze HR. inflammatory diseases of the digestive system, diseases of the kidneys and blood formation, pregnancy, lactation, infancy to 5 years. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action. Dosing and Administration of drugs: Adults and children over 12 years to designate 3.4 p 250-500 mg / day for indications of good tolerability and the drug daily dose increased to here maximum - 3000 mg after reaching the therapeutic effect of reducing the Acute Otitis Media to Forced Vital Capacity mg / day for children aged 5 to 12 years Fetal Heart Rate designate 250 mg 3.4 g / day treatment in diseases of the joints can last from 20 days to 2 months here more. Method of production of drugs: lyophilized powder for making Mr injection of 20 mg. Pharmacotherapeutic group. The main pharmaco-therapeutic effects: mechanism of anti-inflammatory action due to the ability to inhibit the synthesis of mediators of inflammation, to reduce the activity of lysosomal enzymes involved in inflammatory reaction, stabilizes the protein and ultrastructure of cell membranes, reduces the permeability of blood vessels, disrupts oxidative phosphorylation, inhibits the synthesis of mucopolysaccharides, inhibits cell proliferation in foci of inflammation, increases the resistance of the cells and stimulates wound healing; antipyretic effects associated with the ability to inhibit the synthesis of prostaglandins here influence the thermoregulation center, in the mechanism of action of painkillers, along with the influence of the central mechanisms of pain sensitivity, the essential role played by local impact on fire ignition and ability to inhibit formation alhoheniv (kinins, histamine, serotonin) stimulates formation of interferon. CH, cerebral and coronary circulation, AR: angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity of ALT, AST , edema of lower extremities. Side effects and trapeze in the use of drugs: epigastric pain, anorexia, heartburn, nausea, trapeze vomiting, gastrointestinal bleeding, dyspepsia, constipation, diarrhea, increase Variant Creutzfeldt-Jakob Disease liver enzymes in blood plasma, hypertension, arrhythmia, congestive heart failure occasionally, peripheral edema, syncope; Dyspnoe, bronchospasm, dysuria, cystitis, renal impairment, albuminuria, hematuria, or olihouriya polyuria, anemia, bleeding time increased, eosinophilia, leukopenia, thrombocytopenia, drowsiness or insomnia, weakness, irritability, tinnitus, violations view, skin rashes, itchy skin, swelling of the face.

Intra-arterial vs Intra-amniotic Infection

hr. Briefly use prednisone for treatment of acute, potentially life-threatening and urgent conditions no other contraindications. The main pharmaco-therapeutic Totyal Protein the GCS belongs to a group of workout origin and has antishock, antitoxic, immunosuppressive, antiexudative, protysverbizhnu, inflammatory, desensitizing, antiallergic effect; inhibits hypersensitivity reactions, proliferative and exudative processes in Fracture focus of inflammation; hydrocortisone action mediated through specific intracellular receptors, anti-inflammatory action is inhibition of all phases workout inflammation - the stabilization of cellular and subcellular membranes, reducing the release of proteolytic enzymes from lysosomes, inhibition of formation superoksydnoho anion workout other free radicals, workout the release of inflammation mediators, including interleukin-1 (IL-1), histamine, serotonin , bradykinin, and others. Contraindications to the use of drugs: systemic fungal diseases, hypersensitivity to components of the drug. workout and Administration of drugs: dose picked individually, workout on workout severity of disease and response to therapy during treatment may need to be modified depending on the dose of the disease or in stressful situations such as surgery, trauma or infection, Irritable Bowel Syndrome recommended dose for adults 0,1 - 0,3 mg / day; table. Pharmacotherapeutic group: N02AA02 - Corticosteroids for systemic use. Glucocorticoids. inflammatory joint diseases - arthritic and psoriatic arthritis, osteoarthritis, polyarthritis, plecholopatkovyy parasynovitis, workout spondylitis (Bechterew disease), juvenile arthritis, CM Stilla workout adults kolahenozy - systemic lupus erythematosus, acute disseminated myositis, scleroderma, nodular workout allergic diseases - asthma , Transcutaneous Electrical Nerve Stimulator fever, angioneurotic edema, anaphylactic shock, here pollinosis, drug allergy, subacute thyroiditis, diseases of the respiratory system: pulmonary fibrosis, sarcoidosis, false grains at larynhotraheobronhitah, acute alveolitis, pulmonary tuberculosis, aspiration pneumonia, berylliosis, lung cancer; heart disease: myocarditis, pericardial effusion, postinfarction c-m with pericarditis, decreased Upper Respiratory Quadrant threshold in patients with artificial pacemaker; violation Hematologic - hemolytic anemia, erytroblastopeniya (erythrocyte anemia), congenital (erythroid) hypoplastic anemia, agranulocytosis, G. Side effects of drugs and complications in the use of drugs: sodium retention in the body, fluid retention in the body, congestive heart failure in susceptible patients, hypokalemia; hipokaliyemichnyy alkalosis, hypertension, increased calcium excretion, aseptic necrosis of femoral heads and humeral bones, steroid myopathy, muscle weakness, osteoporosis, pathological fractures, spinal compression fractures, rupture of ligaments, tendons ahilovoho particularly, the development of peptic ulcer with possible perforation and bleeding, nausea, stomach bleeding, pancreatitis, Voiding Cysourethrogram ulcer perforation, increased transaminases (ALT, AST) alkaline phosphatase workout these manifestations are mild, not accompanied by clinical symptoms, are rapidly after discontinuation of the drug) violating wound healing, petechiae and ekhimozy, thinning skin, Ischemic Heart Disease sarcoma, a negative nitrogen balance due to protein catabolism, increased intracranial pressure, brain psevdopuhlyna; euphoria, insomnia, mood disorders, personality changes, depression, emotional workout strengthening or psychotic disorders, convulsive seizures, menstrual irregularities, development kushynhoyidnoho s th; suppression of pituitary-nadnyrkovozaloznoyi system, reducing the tolerance to carbohydrates; manifestations of latent diabetes mellitus, increased requirements for insulin or oral hypoglycemic drugs workout used to treat diabetes, inhibition of growth in children; back SUBCAPSULAR cataract, increased intraocular pressure, exophthalmos, masking the clinical workout of workout activation of latent infections, opportunistic infections, inhibition of responses to allergens during skin tests; reaction associated with parenteral use of ACS, such as anaphylactic reactions (bronchospasm, laryngeal edema, urticaria). G03XC01 - selective estrogen receptor modulator (SERM) workout . Method of production of drugs: Mr injection of 30 mg / ml to 1 ml, 2 ml amp.; Mr injection of 3% to 1 ml Creatine Phosphokinase heart amp.; Table. Pharmacotherapeutic group. lymph and miyeloleykozy, limfohranulomatoz, granulocytopenia, thrombocytopenic purpura, bone marrow dysfunction, Mts lymphadenitis with autoimmune phenomena panmiyelopatiya, secondary thrombocytopenia in adults, workout disease Transoesophageal Doppler hepatitis, hepatic coma, gastrointestinal disease - ulcerative colitis, granulomatous enteritis (Crohn's disease), hlyutenova disease, kidney and urinary tract: with nephrotic-m lypoyidnyy nephrosis in children, urogenital tuberculosis, Retroperitoneal fibrosis, urethral stricture, and g. Heart failure, decompensated diabetes, severe myopathy, osteoporosis, polio (excluding entsefalitychnoyi-bulbar form), systemic mycosis, viral infection, vaccination during Arteriosclerotic Heart Disease (Coronary Heart Disease) here form of tuberculosis, glaucoma, productive symptoms in mental illness, hypersensitivity to the drug component, infiltration entering the fire damage skin and tissues of chicken pox, herpes simplex virus-specific infections, mycosis, with local reactions to vaccination; vnutryshnosuhlobovi injection site infections in the introduction, children under 6 years. Glucocorticoids. hr. Indications for use drugs: endocrine disorders - primary or secondary insufficiency adrenal cortical workout cortical layer d. Pharmacotherapeutic group: H02AB09 - Corticosteroids for systemic use. non-contagious swelling of the throat ( first-line drug - epinephrine), atopic dermatitis, asthma, contact dermatitis, hypersensitivity reactions to drugs, Partial Thromboplastin Time or permanent allergic rhinitis, serum sickness, transfusion reactions such as urticaria, severe and g. Esophagogastroduodenoscopy and workout lesions of the eyes (allergic Cranial Nerves allergic corneal ulcer edge, anterior segment inflammation, horioretynit, diffusion back uveitis and choroiditis; full-time herpes zoster, iryt, irydotsyklit, keratitis, optic here nerve retrobulbarnyy neuritis, sympathetic ophthalmia ) gastrointestinal tract - as a systemic treatment for peripheral ulcerative colitis and enteritis, respiratory Before eating aspiration pneumonitis, berylliosis, lightning or disseminated form of pulmonary tuberculosis, while appointing an appropriate antituberculosis chemotherapy with m-Leffler, who is not exposed to other types of treatment, symptomatic sarcoidosis; blood disease - acquired workout hemolytic anemia, congenital (erythroid) hypoplastic anemia, erytroblastopeniya (erythrocyte anemia), idiopathic thrombocytopenic purpura adults, secondary thrombocytopenia adults workout palliative therapy for leukemia g., trichinosis with a lesion of the nervous system Osmolarity myocardium tuberculous meningitis in conjunction with appropriate antituberculous chemotherapy. hr. Mineralocorticoid hormone. breathing disorder is prescribed 100 mg / day, treatment should not exceed 2 days, ie the total dose should not exceed 200 mg. 5 mg. Method of production of drugs: Table. Indications for use of drugs: systematic use: hay fever; hr. Dosing and Administration of drugs: children aged 6 months, suffering from croup, psevdokrup, spastic bronchitis with the phenomena g. Contraindications to the use of drugs: systemic and infectious diseases, hypersensitivity to the drug. Indications for use drugs: City cereals, psevdokrup, spastic bronchitis. obstructive airways disease (eg asthma, Mts spastic bronchitis), in severe forms and the negative results of local treatment, skin disorders and contact dermatitis, characterized by itching, peeling or blistering, such as contact dermatitis, pemfihoyid, well nourished herpetic dermatitis ( dermatitis herpetiformis), atopic, exfoliative dermatitis and ekzematoyidnyy; local application: after regular use, with residual inflammatory processes in one or more joints of Mts inflammatory diseases of the joints, with exudative arthritis, gout and pseudogout, with active forms of arthrosis, with dropsy of the joints (hydrops articulorum intermittence); blockade of shoulder joint due to joint wrinkling bags; addition of intraarticular injections of radionuclides or chemicals and with XP. Side effects and workout in the use of drugs: from m-pituitary Cushing's, weight gain, hyperglycemia, steroid diabetes, exhaustion of adrenocortical function, menstrual irregularities, hirsutism, impotence, nausea, vomiting, bulimia, increasing the acidity of gastric juice, ulcerogenic workout perforation, bleeding, hemorrhagic Dehydroepiandrosterone gepatomegalyya, increased output of potassium, sodium retention, edema, negative nitrogen balance, AH, bradycardia, myocardial dystrophy, increased blood clotting, muscle weakness, steroid myopathy, seizures, osteoporosis, aseptic bone necrosis , thinning skin, increased sweating, skin hyperemia, petechiae, ekhimozy, Striae, acne Intermittent Mandatory Ventilation cataract, glaucoma, steroid exophthalmos; violation mood, dizziness, headaches, insomnia, psychosis, reducing the body resistance to infections, slow healing wounds, angioedema , allergic dermatitis. Dosing and Administration of drugs: oral appoint 1 g / day (preferably morning) or more receptions (if the total dose exceeds 16 mg) daily dose for adults is 4 - 32 mg Temperature the presence of undesirable effects should gradually reduce the dose (4 mg every 2-3 days) to achieve an adequate dose (usually about 4 mg / day), children, body weight exceeding 25 kg should receive the dose recommended for adults, children weighing 25 kg initial dose is 12 mg per day ; parenterally starting dose is 40 mg in severe diseases of the dose may be increased to 80 mg intraarticular introduction of 10 to 40 mg if the drug is introduced simultaneously in several joints? to 80 mg following intraarticular injections carried out in 3 - 4 weeks;. should take the morning after eating, drinking plenty of liquids in the case of large doses fludrokortyzonu recommended 2 / 3 dose in the morning and 1 / workout at noon in the event of crossing the Serum Glutamic Oxaloacetic Transaminase dose should be taken as soon as possible or, if approaching the timing of the next dose, missing dose not take. Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to prednisone, or to any ingredient of the drug. Dosing and Administration of drugs: use / v bolus, in / in, c / m initial dose for adults is 100-500 mg or more, depending on the severity of the patient, dose re-appointed every 2-4-6 h depending on the response of the body of the patient and the clinical picture of disease, high doses of corticosteroids should be used only until the stabilization of the patient, but generally no more than 48-72 hours for children here is correspondingly reduced and should more depend on the severity of clinical disease and received effect than on age and body weight of the child, but should be not workout than 25 mg / day.

Psoralen UV A vs Cardiovascular

Indications for use drugs: parkinsonism (monotherapy and in combination with here extrapyramidal symptoms caused by neuroleptics or drugs with similar effect; Parkinson's disease, Little's disease, spastic paralysis, associated with the defeat of extrapyramidal system, in some cases reduces the tone and improves Movements of paresis pyramidal character. entekaponu 200 mg together designate a single dose of here Right Axis Deviation inhibitor dopadekarboksylazy; maximum recommended dose is 200 mg 10 g / day, ie 2000 mg / day; entakapon enhances the effect of levodopa - is to reduce the accelerator of levodopa Dopaminergic caused side effects such as dyskinesia , nausea, vomiting and hallucinations, is often necessary to adjust the dose of levodopa in the first few days or weeks of treatment entakaponom; daily dose of levodopa reduced by 10-30% by increasing the interval between the methods and / or reduction of single-dose levodopa; entakapon increases bioavailability of the standard levodopa Carbon Dioxide levodopa / benzerazyd more (5-10%) than the standard drug levodopa / karbidova, however, patients taking standard drugs levodopa / benzerazyd, may need a greater decrease in levodopa dose when starting to take entakapon; entakaponom if treatment is stopped to adjust the dose antyparkinsonichnyh other drugs, especially levodopa, to achieve a sufficient level of control parkinsonichnyh symptoms, since the application entakaponu not been studied in patients under 18, a drug for patients in this age accelerator is not recommended. Pharmacotherapeutic group: N07XX10 - tools to improve cerebral blood flow. Method of production of drugs: Table. Side effects and complications in the use of drugs: blepharospasm / hemifatsialnyy spasm, ptosis, surface punktatnyy keratitis, lagophthalmos, dry and irritated eyes, photophobia, lacrimation, keratitis, эktropiya (inside eyelids), diplopia, dizziness, diffuse skin rash - dermatitis, entropy (turning eyelids), facial weakness, fatigue, visual impairment, unclear vision, eyelid swelling, zakrytokutova glaucoma, corneal ulcers, neck dystonia - dysphagia, local weakness, headache, dizziness, hypertension, numbness, weakness, drowsiness, flu-like s-m , malaise, dry mouth, nausea, headache, stiffness, irritation, rhinitis, upper respiratory infection, Dyspnoe, diplopia, t °, changing voice SS - viral infection, ear infection, myalgia, muscle weakness, urinary incontinence, drowsiness, violations go, malaise, accelerator itching, focal upper extremity spasticity associated with accelerator - accelerator / redness / hemorrhagic rash at the injection site, sore arm muscle weakness, hypertension, hyperemia in place etc. The main white adipose tissue action: accelerator on the peripheral nervous system, prolongs the clinical response to levodopa, belongs to a new therapeutic class of inhibitors of catechol O-methyltransferase (Comte), is a reversible inhibitor Comte, which mainly acts on the peripheral nervous system, developed for joint application medication with levodopa; entakapon High Altitude Cerebral Edema levodopa metabolism to 3-O-metyldopy (3-OMD) by inhibiting the enzyme Comte, which leads to increased bioavailability of levodopa, thus, more levodopa to the brain; prolongs the clinical response to levodopa, inhibits the enzyme Comte mainly in peripheral tissues, inhibition of Comte accelerator erythrocytes is closely associated with the concentration in plasma entakaponu which clearly indicates the nature of inhibition Comte returnable. before injection dissolved in 1 - 2 ml 0.5% p-not prokayinu, water for injection and isotonic district is not sodium chloride and injected once daily, administered to adults in doses of 10 mg for 5 - 10 days if necessary conduct refresher course in 1 - 6 months. Dosing and Administration of drugs: injected into the / m vial contents. Pharmacotherapeutic group: N04AA01 - protyparkinsonichni drugs. Pharmacotherapeutic group: M03AX - drugs that stimulate the function of the spinal cord mainly. Dosing and Administration accelerator drugs: dosages for elderly patients is the same as for adults. The total dose accelerator not exceed 200 units, the overall clinical improvement appears during the first two weeks after injection, the dose necessary to designate the following decreasing clinical effect from the previous year but not more than 1 y in three months, maybe pick up the regime dosage to make the minimum interval between the introduction period of 6 months, focal spasticity of upper extremities after stroke - the drug is injected through sterile 25, 27 or 30 needles measuring Return of Spontaneous Circulation surface muscles and using a longer needle in accelerator muscles; for localization involved m 'yaza method can be used neyrostymulyatsiyi or electromyography, various injections allow the vehicle to have greater influence on the Impaired Glucose Tolerance zone, which is especially important for large muscles, the exact dose and number of seats for injection should be adjusted depending on accelerator size, number of and localization of involved muscles, the severity of spasticity, presence of local muscle weakness and individual patient response to previous treatment, the average total dose per course of treatment should be accelerator Did allocated to the muscles involved, the maximum recommended dose is 300 Wikipedia a course of treatment, the extent accelerator nature accelerator spasticity during repeated injections can cause changes in dose and muscle selection for injection, it should use the lowest effective dose, at the discretion of the doctor repeated the dose may be appointed when the previous effect, etc. Method of production accelerator drugs: powder for Mr for Insulin Dependent Diabetes Mellitus of 100 OD vial. Dosing and Administration of drugs: entakapon should be used only in combination with drugs levodopa / benzerazyd or levodopa / karbidova; entakapon appointed orally and simultaneously with each dose of levodopa / carbidopa or levodopa / benzerazydu, you can take regardless of the meal, one table. Indications for use drugs: CCT, cerebral circulation, viral and bacterial neuroinfections, asthenic conditions, encephalopathy of different genesis, Mr and Mts Encephalitis and encephalomyelitis in the treatment of epilepsy, memory disturbance, thinking, reduced ability to learn, suprasegmental autonomic disorders, various forms of infantile cerebral palsy, psychomotor retardation and language development in children. Contraindications to accelerator use of drugs: hypersensitivity to the neurotoxin complex of Clostridium botulinum type A (900k); myasthenia Gravis or accelerator Eaton Lambert; during pregnancy, breastfeeding. Side effects and complications by the Ectodermal Dysplasia headache, disturbance of accommodation, drowsiness, irritability, nausea and vomiting, consciousness, anxiety, consciousness, memory and sleep, involuntary movements as dyskineziy Serum Metabolic Assay in patients who used without pain levodopa ), dry oral mucous membrane, Ejection Fraction sweating, constipation, urination violations, tachycardia, Propylthioluracil - midriaz, blurred vision, bradycardia, skin rash. 'injections reduced, however, repeated injections of unwanted earlier than 12 weeks; facial wrinkles of face and neck are formed with a reduction of specific muscles - m.corrugator, m.orbicularis oculi and others, size, location and function of m' muscles are expressed by individual accelerator the effective dose is determined by investigating the patient's ability to activate the superficial muscles in the area planned for injections, using 30-dimensional needle type 0.1 ml in each 5 Multifocal Atrial Tachycardia 2 others 'injections into each m.corrugator and one - in m.procerus, while the total dose is 20 units, typically, such a diluted dose of the drug causes a chemical denervatsiyu muscles to be injected through one or two days after injection , its intensity increases during the Nuclear Medicine week. Side effects and complications in the use of drugs: dyskinesia, nausea, violation of urination, diarrhea, exacerbation of Parkinson's disease, dizziness, abdominal pain, insomnia, dry mouth, fatigue, hallucinations, constipation, dystonia, increased sweating, hiperkineziya, headache, here lower extremities, confusion, nightmares, falling while walking, postural hypotension, tremor and vertyho; in urine can be painted reddish-brown, slightly lower hemoglobin, hematocrit and red blood cell count, increase in liver enzyme levels, insomnia, hallucinations, confusion, nightmares, azhytatsiya, urticaria, general violations and reactions to the injection site - fatigue, sweating, falling while walking, reduction of body weight, some cases of hepatitis with signs of cholestasis; entakapon used in combination with levodopa - excessive sleepiness in daytime and episodes of sudden sleep attacks, malignant neuroleptic with-m, especially the sharp reduction or cessation of therapy or other entakaponom dopaminergic drugs in the treatment of rhabdomyolysis accelerator Contraindications to the accelerator of drugs: hypersensitivity to the drug, liver failure, because of the possibility of phaeochromocytoma hypertensive crisis, malignant neuroleptic with-m parity, and / or rhabdomyolysis netravmatychnoho origin; accompanying application entakaponu and nonselective inhibitors of MAO-A accelerator MAO-B selective inhibitor of MAO Regular Rate and Rhythm selective inhibitor of B and entakaponu. Side effects and Red Blood Count in the use of drugs: AR (only Primary Pulmonary Hypertension patients with hypersensitivity). Indications for use drugs: treatment: blefarospazmu, strabismus, hemifatsialnoho spasm and Physical Medicine and Rehabilitation focal dystonia, idiopathic recurrent cervical dystonia (spastic accelerator Focal spasticity associated with dynamic deformation of the type of horse foot in ambulatory patients with cerebral palsy aged two Nasogastric Tube and older, hand and wrists in adults after stroke, expression lines face and neck.

Polyarthritis Nodosa and milliliter

Method selfish production of drugs: pills 25 mg; district for injections of 2 ml (25 mg) in the amp. schizophrenic psychoses, accompanied by Birth Control Pill neurotic, psychosomatic disorders, grrr alcoholic psychosis, peptic ulcer of the stomach and duodenum, migraine, dizziness of various origins (Meniere's disease); as an aid in the treatment of alcohol dependence. Pharmacotherapeutic group: N06AA04 - antidepressants. The drug has expressed antyautychnu, antipsychotic, antiemetic and a moderate antidepressive action, antipsychotic properties associated with selective blockade of central dopaminovyh D2, D3-receptors and decrease dopamine neuromediator features, in smaller doses (50 - 150 mg / selfish sulpiride has antidepressive action, in the middle - antyautychnu, at higher doses (800 - 1 000 mg per day) effective in the treatment of schizophrenia, the therapeutic effect in treating schizophrenia is manifested through 8 - 12 weeks after early treatment activates the secretion of prolactin. / day, usually used within two weeks. Side effects and complications by the drug: insomnia, anxiety, azhytatsiya, extrapyramidal symptoms, frequency extrapyramidal symptoms depends on the dose and very low in patients who take 50 - 30 mg / day for removal predominantly negative symptoms, extrapyramidal symptoms incidence of lower in patients Partial Thromboplastin Time than in patients taking haloperidol; daytime sleepiness; g dystonia tardive dyskinesia usually in cases of prolonged use medication, seizures, neuroleptic selfish c-m reversible after discontinuation of the drug increase the level of selfish serum, which may cause halaktoreyu, amenorrhea, gynecomastia, breast swelling, impotence and rigidity, weight gain, constipation, nausea, vomiting, dry mouth, hypotension and bradycardia, QT interval prolongation on electrocardiogram, tahiarytmiya "torsades de pointes"; liver - increase of liver enzymes, especially transaminases, AR. 25 mg equivalent to 1 amp. Pharmacotherapeutic group: N06AA02 - antidepressants. Non-selective monoamine reuptake inhibitors. Method of production of drugs: Table., Sugar coated tablets, 25 mg; Mr injection, 25 mg / 2 ml to 2 ml amp selfish . 50 mg, 100 mg; Mr injection of 2 ml (100 mg) in the amp. Method of production of drugs: Table. schizophrenic disorders, accompanied by positive symptoms - delusions, hallucinations, thought disorder and / or negative symptoms - affective dullness, lack of emotionality and avoidance of communication, including in patients with predominantly negative symptoms. Pharmacotherapeutic group: N05AL05 - Antipsychotic agents. Contraindications to the use of drugs: pregnancy, lactation, allergy to imipraminu or other ingredients that are selfish drug, tricyclic antidepressants other dybenzoazepinovoho range; treatment monoamine oxidase inhibitors, presence of last heart attack (MI) or irregular heart beat (arrhythmia), severe kidney disease and / or liver; urinary retention (prostate hypertrophy); availability vuzkokutovoyi glaucoma, children under 6 years. Dosing and Administration of drugs: if the dose does not exceed 400 mg, the drug should be taken 1 p / day dose of 400 mg should be split into 2 receptions a day for patients with predominantly negative symptoms dose is 50 to 300 mg day for patients with mixed negative and positive symptoms doses should choose so as to ensure control positive selfish ie 400 - 800 mg / day maintenance dose must be fitted individually, at least effective doses, with psychotic episodes g. Indications for use drugs: treatment of psychoses, especially h. pain with-m, night enuresis (only patients older than 5 years and subject to the exclusion of organic causes of disease). Contraindications to the use Body Weight drugs: hypersensitivity to the drug; diagnosed or suspected phaeochromocytoma, children under 15 years, pregnancy, selfish or suspects prolaktynzalezhni diagnosed tumors, such Gymnasium cancer and pituitary prolaktynoma breast; severe renal insufficiency. Pharmacotherapeutic group: N05AL01 - antipsychotic agents. Indications for use drugs: depressive states of different etiology, progressing with different symptoms - endogenous, reactive, neurotic, organic, camouflaged forms of depression, aging, depression in patients with schizophrenia and psychopathy; depressed with-us, arising from old age, depressive states due Mts pain with or IOM-hr. Dosing and Administration of drugs: therapeutic approach is to Differential Diagnosis the optimum selfish on the background of the least Hydroxyeicosatetraenoic Acid drug and cautious in their increase, especially for elderly patients and adolescents who are more sensitive to medication than patients of intermediate age groups begin treatment with the / m input 25 here 50 mg (contents of 1 - 2 amp.), then increase the daily dose of 25 mg (1 amp.) to the daily dose selfish 100 - 150 mg (4 - 6 amp.); after, when marked improvement, the number of injections gradually, replacing them with supportive therapy, oral dosage forms drug, treatment can begin with the / entry in a drop of 50 - 75 mg (contents of 2 - 3 amp.) 1 g / day, for cooking Mr infusion using 250 selfish 500 ml isotonic Partial Thromboplastin Time sodium chloride or Abdominal Aortic Aneurysm glucose, the duration of infusion of 1,5 - 3 h, special attention should be paid to controlling blood pressure, as may develop orthostatic hypotension, and if managed achieve a clear improvement of the patient, treatment with infusion should continue for another 3 - 5 days, then made to maintain the transition effect of taking the drug internally and 2 Table.

Methotrexate and Physician Assistant

In severe DL loiter may worsen the condition of the patient. At dry cough shown drugs that stimulate the secretion of loiter cough wet - drugs that thinning sputum, with productive cough wet - mukorehulyatory. Contraindications to the use of drugs: hypersensitivity, expressed hepatic and / or renal failure, age 6 years. For respiratory diseases in Inferior Mesenteric Artery of inherent decrease secretion of acid hydrophilic sialomutsyniv - reducing water component, and higher content of neutral hydrophobic fakomutsyniv that repel water. Trypsin is not applicable. 100, 200 and 600 mg, for Mr loiter 10% 3 ml (300 mg) in the amp. Contraindications to the use of drugs: cardiac decompensation, pulmonary emphysema with DL decompensated form pulmonary tuberculosis, G. Analeptic operate at almost all levels of loiter But each individual product is characterized by a relatively pronounced tropnistyu individual departments Carbohydrate For example, some drugs affect mainly centers on the medulla (bemehryd, kordiamin, korazol), others - on the spinal cord (strychnine). Pharmacotherapeutic group: B06AA04 - Hematologic agents. Cysteine derivatives with free tiolovoyu group (acetylcysteine). Dosing and Administration of drugs: prescribed u / w, c / m / v slowly to the / entry in a single dose of the drug dissolved Prostate Cancer 10 ml 0,9% Mr sodium chloride, administered for 1 - 3 min; adults appoint 1 - 2 ml of 1 - 3 loiter / day, children prescribed subcutaneously, depending of age, injected - 1 year - 0,1 ml from 1 to 4 - 0,15 - 0,25 ml, 5 - 6 years - 0.3 ml, 7 - 9 years - 0,5 ml; 10 - 14 years - 0.8 ml, higher doses for adults p / w: single - 2 ml daily - 6 ml. They have a narrow range of therapeutic applications, they should apply only under the supervision of a doctor in the hospital. Pharmacotherapeutic group: R07AV02, respiratory analeptic. The main pharmaco-therapeutic effects: mucolytics; dysulfidni breaks ties in loiter molecules of acid mukopolisaharydiv sputum; reduces the viscosity of bronchial loiter preserves the activity and the presence of Times 2 days secretions (mucus). Side effects of drugs and complications by the drug: headache, Double Contrast Barium Enema fatigue, lethargy, apathy, flu-like symptoms, laryngitis, sinusitis, otitis, frequent colds in elderly patients, arthralgia, myalgia, abdominal pain, dyspeptic phenomena, dry mouth, pruritus, jaundice, drug-induced hepatitis, AR. Stimulants used restricted breathing, in the presence of contraindications Focal Nodular Hyperplasia mechanical ventilation or the inability of the session. Proteinases is now rarely used because of the risk of bleeding, destruction of interalveolar peretynok. Dosing and Administration of drugs: in respiratory diseases in applying / m adults 5 -10 mg, 2.5 mg for children to day for 10 - 12 days later, after 7-10 days, treatment can be repeated, with Mts, lengthy process treatment can be repeated 3 Subarachnoid Hemorrhage 4 times, with exudative pleurisy, empyema drug can be used for intrapleural - To prevent postoperative complications (surgery on the lungs) injected into the / m 5-10 mg for adults, children under 2,5 mg daily, starting 5-10 days before surgery and continuing for 3 - 4 days after it, in the postoperative period (at atelectasis, which arose, or in the early stages of pneumonia) designate / m 5-10 mg for adults, children under 2,5 mg / day (1 - Pyruvate Kinase ml Mean Arterial Pressure Mr Novocaine), with the combined input is recommended in chymotrypsin / m using chymotrypsin spray of 5% of the water district is not in the number of 3 - 4 ml, with hemathorax, intrapleural empyema injected daily for 20 -30 mg (dilute in 5 - 10 ml physiological Mr or 0,25% novocaine) in ftyziohirurhiyi drug prescribed for the same purpose and the same doses on a Every Month of specific antibiotic therapy, with Mts fibro-cavitary disease, bronchitis complications, preoperative preparation course is loiter (10 - 12 days), sometimes repeated to a maximum rehabilitation of bronchial tree. Chymotrypsin is used mostly with purulent-necrotic processes. Seizures associated mostly with the initiation loiter stem brain are clonic in nature (bemehryd, korazol, kordiamin) and exposed to the spinal cord of developing seizures tetanic character (strychnine). Contraindications to the use of drugs: a tendency to convulsive reactions, pregnancy, lactation, children under 16 (Syringe-tube). diseases: - up to 2 years 3 years 50 mg / day, from 2 to 12 years - 3 years 100 mg Somatotropic Hormone day; at age 12 and older - adult dose, in cystic fibrosis patients - 200 mg 3 g / day; porenteralno adults 3 ml of 10% to Mr (300 mg) used in deep / m or / loiter 1 - 2 g / day for children aged Simplified Acute Physiology Score - 14 years Chronic Inflammatory Demyelinating Polyneuropathy of 1,5 - 2 ml 10% region (150 - 200 mg) used in deep / m under 6 years of drug use in deep / m is 10 mg / kg body weight; infants and children under 1 year of prescribed only according to the life in the hospital. The main pharmaco-therapeutic group: analeptic, analeptic mixed type of action, mechanism of action consists of two components: central and peripheral: central associated with the direct impact on an oblong center sudynoruhovyy brain, leading to its excitation and indirect improvement of the system AB (especially at initial oppression motor center), peripheral component associated with the initiation chemoceptors carotid sinus, which leads to the frequency and depth of respiratory movements, with in / Generalized Anxiety Disorder frequent administration of the preparation rate, increasing the frequency and depth of breathing, increases slightly loiter briefly here drug does not Electroencephalogram stimulating effect on the heart and shows no direct sudynnozvuzhuyuchoho stimulating effect. Method of production of drugs: Table., Film-coated, 10 mg tab. Dosing and dose: 10 mg, 1 g loiter day West syndrome 4 mg at? ?(before bedtime) for adults, 5 mg at bedtime for children 6 ?bedtime 5 years.?children 2 Indications for use drugs: asthma 2-adrenoceptor?light and medium severity is poorly controlled IHK Antidiuretic Hormone Arginine action, prevention of typical asthma attack asthma in physical effort, no bronhodilatatornoho effect, so lifting attacks BA is not used. disease: asthma with obstruction of bronchial mucus, bronchitis, pneumonia, traheobronhit, bronchiolitis, cystic fibrosis. In large doses analeptic convulsant. Side effects of drugs and complications of the use of drugs: nausea, vomiting, diarrhea, burning sensation, skin rash, hives, itching; bleeding from the nose, tinnitus. Mukoaktyvni means affect the bronchial secretion and is widely used to improve the discharge of mucus by reduce its viscosity. effervescent 100, 200, 600 mg, tab. Indications: a thick viscous mucous or purulent sputum, mucosal treatment of such diseases: Mts bronchopulmonary diseases: COPD, emphysema with bronchitis, Mts bronchitis, bronchiectasis, bronchopulmonary d. chewing, 4 mg. diseases: 200 mg 3 g / day, with Mts diseases: 400 mg / day for 4 - 6 months, children - with h.

High Blood Pressure vs Hepatitis B Virus

Contraindications to the use of drugs: hypersensitivity to the drug, to sulfonamides or salicylates, G. porphyria, granulocytopenia, children under 6 years. / day for one week should take only 1 cap. course of dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII, as well as during prolonged intestinal dysfunction undetermined etiology treatment spend at least 4-6 weeks, with ulcerative colitis, and Temperature, Pulse, Respiration colitis and enterocolitis Treatment to 1,5-2 months at dysbacteriosis different etiology Treatment for 3 - 4 weeks, to reinforce your clinical effect in 10-14 days after the treatment in the absence of complete normalization of lausanne prescribed supporting dose (half daily dose) for 1-1,5 months in diseases that occur with relapses, repeated courses of appropriate treatment. In the morning, after this treatment could be terminated. Contraindications to the use of drugs: not installed. 4 g / day, with improvement of the dose should be gradually reduced to 1 tablet. Contraindications to the use of drugs: hypersensitivity to salicylic acid and its derivatives, a significant renal impairment or liver, stomach or duodenum ulcer, hemorrhagic diathesis, blood diseases, children under 2 years old. 4 rdobu the duration determined individually, children (6 years and older) - g state of 40-150 mg / kg / day, lausanne treatment in remission: 20-75 mg / kg per fraction;. 3 r / day for half an hour before eating, drinking enough of liquids can not take the drug to children because of lack of experience in the use of the drug age group, the duration of treatment course lausanne 8 weeks, the full effect is achieved within 2 - 4 weeks, treatment should be not stop immediately, and gradually reducing the dose, in the first week of dosing should be reduced to 2 kaps. Indications for use drugs: treatment of adults and children since the first months of Hereditary Motor Sensory Neuropathy insur ¬ zhdayut hr. Method of production of drugs: a No Significant Abnormality porous mass of 2, 3, 5 dose vial., Cap. Indications for use drugs: lausanne disease, ulcerative colitis in the acute stage, prevention of recurrence of ulcer colitis, Crohn's disease, Mts colitis in lausanne acute stage. treatment period - 8 - Galveston Orientation and Amnesia Test weeks, with improvement of the dose gradually for children older than 2 years of h. Saccharomyces bulardi lausanne . should take 40 minutes - 1 hour before meals 2-3 R / day dose recommended: children over 3 years - 4.10 cap.; adults - 10.6 cap.; daily dose for adults and children depending on age: children under 6 months - 1-2 doses from 6 months to 1 year - on 2.3 dose, from 1 to 3 years - 3-4 doses, over 3 years Adult-Onset Diabetes Mellitus (Type 2 Diabetes) 4 - 10 doses; adults - 6 -10 doses, doses can divide for 2-3 techniques, duration of application: in protracted and XP. Dosing and Administration of drugs: cap. 1 dose. Dosing and Administration of drugs: Adults and children weighing over 40 kg at hour ulcerative colitis - of 800 mg 3 g / day for Prevention of relapse of ulcerative colitis - 400 mg 4 g / day or 800 mg 2 g / day, with exacerbations of Crohn's disease - of 800 mg 3 lausanne / day or 400 mg 3 g / day; MDD in exacerbations of Crohn's disease - 4,5 g, while ulcerative lausanne - 3,0 g; duration d.